Soma C E, Dubernet C, Barratt G, Benita S, Couvreur P
Centre d'Etudes Pharmaceutiques, UMR CNRS 8612, 5 rue J.B. Clément, 92296 Cedex, Châtenay-Malabry, France.
J Control Release. 2000 Aug 10;68(2):283-9. doi: 10.1016/s0168-3659(00)00269-8.
Doxorubicin-loaded PACA nanoparticles have been shown to be more efficient than free drug in mice bearing hepatic metastasis of the M5076 tumour. Due to the high phagocytic activity of Küpffer cells in the liver, it may be that these cells played a role of drug reservoir after nanoparticle phagocytosis. Therefore, the objective of this study was to assess the role of macrophages in mediating the cytotoxicity of doxorubicin-loaded nanoparticles on M5076 cells. The growth inhibition of tumour cells was evaluated in two ways: firstly, the cells were incubated in a coculture system consisting of special wells with two compartments separated by a porous membrane. M5076 cells were seeded into the lower compartment and the macrophages J774.A1 were introduced into the upper part. The macrophages were activated or not by IFN-gamma. The drug preparations were added only in the macrophage insert. Secondly, growth inhibition was also assessed in the conventional way, i.e. in direct contact with the tumour cells to serve as a reference. After direct contact, free doxorubicin (Dox) and doxorubicin-loaded nanoparticles (NP-Dox) had the same efficacy against M5076 cell growth. The coculture experiments led to a 5-fold increase in the IC(50) for both Dox and NP-Dox. The activation of macrophages by IFN-gamma in coculture significantly decreased the IC(50) values. In conclusion, after phagocytosis of doxorubicin-loaded nanoparticles, J774.A1 cells were able to release active drug, allowing it to exert its cytotoxicity against M5076 cells. Drug efficacy was potentiated by the activation of macrophages releasing cytotoxic factors such as NO, which resulted in increased tumour cell death. Thereby, the coculture system permitted us to investigate the macrophage-mediated cytotoxicity of colloidal carriers loaded with an anticancer drug, which is of great interest when further i.v. administration is envisaged.
载有多柔比星的聚(N - 丙烯酰甘氨酸)纳米颗粒在携带M5076肿瘤肝转移的小鼠中已显示出比游离药物更有效。由于肝脏中枯否细胞的高吞噬活性,可能这些细胞在纳米颗粒吞噬后起到了药物储存库的作用。因此,本研究的目的是评估巨噬细胞在介导载有多柔比星的纳米颗粒对M5076细胞的细胞毒性中的作用。通过两种方式评估肿瘤细胞的生长抑制:首先,将细胞在由具有两个隔室且由多孔膜分隔的特殊孔组成的共培养系统中孵育。将M5076细胞接种到下部隔室中,并将巨噬细胞J774.A1引入上部。巨噬细胞用IFN - γ激活或未激活。药物制剂仅添加到巨噬细胞插入物中。其次,也以传统方式评估生长抑制,即与肿瘤细胞直接接触作为对照。直接接触后,游离多柔比星(Dox)和载有多柔比星的纳米颗粒(NP - Dox)对M5076细胞生长具有相同的功效。共培养实验导致Dox和NP - Dox的IC50增加了5倍。共培养中IFN - γ对巨噬细胞的激活显著降低了IC50值。总之,在吞噬载有多柔比星的纳米颗粒后,J774.A1细胞能够释放活性药物,使其对M5076细胞发挥细胞毒性。巨噬细胞释放诸如NO等细胞毒性因子的激活增强了药物疗效,导致肿瘤细胞死亡增加。因此,共培养系统使我们能够研究载有抗癌药物的胶体载体的巨噬细胞介导的细胞毒性,这在设想进一步静脉内给药时具有极大的意义。